Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Classificação em ações #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Preço da ação
$62.83
Valor de mercado
$93.23B
Variação (1 dia)
-9.17%
Variação (1 ano)
-31.36%
País
US
Negociar Boston Scientific Corporation (BSX)

Categoria

Rácio P/S de Boston Scientific Corporation (BSX)
Rácio P/S em April 2026 TTM: 4.64
De acordo com os relatórios financeiros mais recentes e o preço das ações da Boston Scientific Corporation, o rácio P/S atual (TTM) é 4.64. No final de 2024, o rácio P/S era 7.85.
Histórico do rácio P/S da Boston Scientific Corporation de 2000 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
2026 (TTM) 4.64 -34.02%
2025 7.03 -10.40%
2024 7.85 33.05%
2023 5.90 13.02%
2022 5.22 2.69%
2021 5.08 -1.08%
2020 5.14 -12.35%
2019 5.86 17.98%
2018 4.97 32.36%
2017 3.75 7.20%
2016 3.50 6.94%
2015 3.27 37.73%
2014 2.38 5.35%
2013 2.26 102.98%
2012 1.11 5.15%
2011 1.06 -28.16%
2010 1.47 -11.19%
2009 1.66 15.03%
2008 1.44 -30.37%
2007 2.07 -26.04%
2006 2.80 -13.13%
2005 3.22 -39.07%
2004 5.29 -39.64%
2003 8.76 48.28%
2002 5.91 57.56%
2001 3.75 79.94%
2000 2.08 0.00%
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
4.02 -13.30%
US
5.01 7.94%
US
3.14 -32.41%
IE
3.14 -32.41%
IE
1.74 -62.48%
DE